Clinical trials
Phase 2 Lung Neoplasms trials in Romania
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 3 |
| 2011 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| AstraZeneca | 1 |
| CSL Behring | 1 |
| Human Genome Sciences Inc. | 1 |
| ImmunoGenesis | 1 |
| Infinity Pharmaceuticals, Inc. | 1 |
| Mirati Therapeutics Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Cachexia | 2 |
| Adenocarcinoma | 1 |
| Carcinoma | 1 |
| Carcinoma, Large Cell | 1 |
| Carcinoma, Squamous Cell | 1 |
| Emaciation | 1 |
| Fatigue | 1 |
| Lung Diseases | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.